FindTrial
Sign In

Primary research of the approach pulmonary-vein isolation plus linear ablation across atrial scar for presistent atrial fibrillation

Primary research of the approach pulmonary-vein isolation plus linear ablation across atrial scar for presistent atrial fibrillation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-16008338
Enrollment
Unknown
Registered
2016-04-21
Start date
2016-05-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

presistent atrial fibrillation

Interventions

Group A:CPVI
B:CPVI+SCARLINE
C:CPVI+STEPWISE

Sponsors

Cardiovascular Disease Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 7d and <3y; 3. Patients undergoing first-time ablation; 4. Refractory to at least 1 AAD; 5. Willing and able to comply with all periablation and follow-up requirements.

Exclusion criteria

Exclusion criteria: 1. Patients with paroxysmal AF; 2. Patients with long-lasting persistent AF(>3y); 3. Left atraia inner diameter>=60mm.

Design outcomes

Primary

MeasureTime frame
recurrence rate;—

Countries

China

Contacts

Public ContactChang Dong

The first affiliated hospital of DaLian Medical University

cdheart@126.com+86 18098875761

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026